# Rivaroxaban in Left Ventricular Thrombus

> **NCT04970576** · PHASE4 · COMPLETED · sponsor: **National Institute of Cardiovascular Diseases, Pakistan** · enrollment: 261 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Left Ventricular Thrombus

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT04970576
- **Lead sponsor:** National Institute of Cardiovascular Diseases, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-25
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04970576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04970576, "Rivaroxaban in Left Ventricular Thrombus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04970576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*